Kidron Miriam (CIK 1409232) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-03-31). Recent activity: Sell ORMP (435,084 shares), Buy LFWD (7,657 shares), Buy ORMP (119,558 shares), Buy ORMP (19,000 shares), Sell ORMP (86,166 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-31 | ORAMED PHARMACEUTICALS INC. (ORMP) | Chief Scientific Officer | Sell | 435,084 | $1.4M |
| 2026-03-27 | Lifeward Ltd. (LFWD) | Director | Buy | 7,657 | $0 |
| 2026-03-18 | ORAMED PHARMACEUTICALS INC. (ORMP) | Chief Scientific Officer | Buy | 119,558 | $0 |
| 2026-01-29 | ORAMED PHARMACEUTICALS INC. (ORMP) | Chief Scientific Officer | Buy | 19,000 | $0 |
| 2026-01-21 | ORAMED PHARMACEUTICALS INC. (ORMP) | Chief Scientific Officer | Sell | 86,166 | $0 |
| 2026-01-05 | ORAMED PHARMACEUTICALS INC. (ORMP) | Chief Scientific Officer | Buy | 121,331 | $0 |
| 2026-01-05 | ORAMED PHARMACEUTICALS INC. (ORMP) | Chief Scientific Officer | Buy | 115,000 | $0 |
| 2025-02-11 | ORAMED PHARMACEUTICALS INC. (ORMP) | Chief Scientific Officer | Buy | 74,000 | $0 |
| 2025-02-11 | ORAMED PHARMACEUTICALS INC. (ORMP) | Chief Scientific Officer | Buy | 52,000 | $0 |
| 2025-02-11 | ORAMED PHARMACEUTICALS INC. (ORMP) | Chief Scientific Officer | Buy | 66,667 | $0 |
Source: SEC Form 4 filings · as of 2026-03-31